Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction

Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction

AIMS We aimed to assess the cost effectiveness of sacubitril/valsartan compared to angiotensin-converting enzyme inhibitors (ACEIs) for the treatment of individuals with chronic heart failure and reduced-ejection fraction (HFrEF) from the perspective of the Swiss health care system....

Full description

Bibliographic Details
Main Authors: Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, David Trueman, Rola Haroun, Céline Deschaseaux, Matthias Schwenkglenks
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2017-11-01
Series:Swiss Medical Weekly
Subjects:
chronic
chronic heart failure
Cost-effectiveness
drug treatment
effectiveness
Failure
Online Access:https://www.smw.ch/index.php/smw/article/view/2401

Internet

https://www.smw.ch/index.php/smw/article/view/2401

Similar Items